scholarly journals Breast Cancer Screening Awareness, Knowledge, and Practice among Arab Women in the United Arab Emirates: A Cross-Sectional Survey

PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e105783 ◽  
Author(s):  
Yusra E. Elobaid ◽  
Tar Ching Aw ◽  
Michal Grivna ◽  
Nico Nagelkerke
2015 ◽  
Vol 15 (23) ◽  
pp. 10157-10164 ◽  
Author(s):  
Tam Truong Donnelly ◽  
Al-Hareth Al Khater ◽  
Salha Bujassoum Al-Bader ◽  
Mohammed Ghaith Al Kuwari ◽  
Mariam Malik ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-13
Author(s):  
Nehad M. Ayoub ◽  
Ghaith M. Al-Taani ◽  
Basima A. Almomani ◽  
Linda Tahaineh ◽  
Khawla Nuseir ◽  
...  

Objectives. Our study is aimed at exploring the knowledge and personal practice of breast cancer screening among female community pharmacists in Jordan. Methods. A cross-sectional survey was carried out using a nonrandom sample selection method for pharmacists in community pharmacies. Results. A total of 551 female pharmacists completed the questionnaire. The mean age of pharmacists was 29.1 ± 7.3 years (range 21–67), and most have bachelor degrees in pharmacy (89.1%). The mean score of knowledge of breast cancer signs and symptoms was 4.2 ± 1.5 out of 6 points (range 0–6). The mean score of knowledge of risk factors was 7.6 ± 1.9 out of 12 points (ranging from 2–12). The mean score for knowledge of screening guidelines was 2.8 ± 0.9 out of 4 points (range 0–4). Overall, 452 pharmacists (85.8%) had acceptable knowledge while 75 pharmacists (14.2%) had poor knowledge of breast cancer. Pharmacists surveyed were aware of the different screening methods of breast cancer. The percentage of pharmacists who has performed breast self-examination (BSE), clinical breast examination (CBE), and mammography was 46.6%, 16.5%, and 5.4%, respectively. The most common reason for the lack of BSE and CBE performance was the absence of breast symptoms. Not being at the age recommended for mammography was the most common reason for not undergoing this screening method. Knowledge and practice of screening methods were influenced by age, years of experience, geographic region, personal history of breast cancer, and educational level among community pharmacists. Conclusions. This study revealed some gaps in the knowledge of breast cancer among female community pharmacists. The practice of the different screening methods was suboptimal, and variable reasons were indicated for the low uptake of these screening methods. Community pharmacists need to practice preventive behaviors to a satisfactory level to encourage women in the community to adopt similar behavior.


2021 ◽  
Vol Volume 13 ◽  
pp. 21-30
Author(s):  
Jessiya Veliyankodan Parambil ◽  
Mostafa Najim ◽  
Mohamed Mahmoud ◽  
Ibrahim Yusuf Abubeker ◽  
Anand Kartha ◽  
...  

2019 ◽  
Vol 22 ◽  
pp. 100206
Author(s):  
Sujha Subramanian ◽  
Robai Gakunga ◽  
Madeleine Jones ◽  
Asaph Kinyanjui ◽  
Emily Ochieng’ ◽  
...  

2021 ◽  
Vol 11 (8) ◽  
pp. 726
Author(s):  
Samuel Alarie ◽  
Julie Hagan ◽  
Gratien Dalpé ◽  
Sina Faraji ◽  
Cynthia Mbuya-Bienge ◽  
...  

The success of risk-stratified approaches in improving population-based breast cancer screening programs depends in no small part on women’s buy-in. Fear of genetic discrimination (GD) could be a potential barrier to genetic testing uptake as part of risk assessment. Thus, the objective of this study was twofold. First, to evaluate Canadian women’s knowledge of the legislative context governing GD. Second, to assess their concerns about the possible use of breast cancer risk levels by insurance companies or employers. We use a cross-sectional survey of 4293 (age: 30–69) women, conducted in four Canadian provinces (Alberta, British Colombia, Ontario and Québec). Canadian women’s knowledge of the regulatory framework for GD is relatively limited, with some gaps and misconceptions noted. About a third (34.7%) of the participants had a lot of concerns about the use of their health information by employers or insurers; another third had some concerns (31.9%), while 20% had no concerns. There is a need to further educate and inform the Canadian public about GD and the legal protections that exist to prevent it. Enhanced knowledge could facilitate the implementation and uptake of risk prediction informed by genetic factors, such as the risk-stratified approach to breast cancer screening that includes risk levels.


BMJ Open ◽  
2015 ◽  
Vol 5 (1) ◽  
pp. e005596-e005596 ◽  
Author(s):  
T. T. Donnelly ◽  
A.-H. Al Khater ◽  
M. G. Al Kuwari ◽  
S. B. Al-Bader ◽  
N. Al-Meer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document